1,985
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Drug-resistant tuberculosis: an experience from Qatar

, , , , , , , & show all
Article: 1744351 | Received 09 Jul 2019, Accepted 22 Jan 2020, Published online: 02 Apr 2020

References

  • World Health Organization. Global tuberculosis report 2017 [Internet]. [cited 2019 Sep 6]. Available from: https://www.who.int/tb/publications/global_report/gtbr2017_main_text.pdf
  • Mitchison DA. Drug resistance in mycobacteria. Br Med Bull. 1984 Jan;40(1):84–6.
  • WHO. Global tuberculosis report 2015 [Internet]. WHO. [cited 2016 Oct 2]. Available from: http://www.who.int/tb/publications/global_report/en/
  • Areeshi MY, Bisht SC, Mandal RK, et al. Prevalence of drug resistance in clinical isolates of tuberculosis from GCC: a literature review from January 2002 to March 2013. J Infect Dev Ctries [Internet]. 2014 Sep 12 [cited 2016 Sep 20];8(9):1137–1147. Available from: http://www.jidc.org/index.php/journal/article/view/4053
  • Al Marri M, Al Hail L, Al Otaibi S, et al. The time of reactivation of tuberculosis in expatriates in the state of Qatar. Qatar Med J. 2006;2006(2):12.
  • Al-Marri MR. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2001 Dec;5(12):1116–1121.
  • Zignol M, van Gemert W, Falzon D, et al. Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing. Clin Infect Dis Off Publ Infect Dis Soc Am. 2011 Apr 1;52(7):901–906.
  • Wright A, Zignol M, Van Deun A, et al. Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the global project on anti-tuberculosis drug resistance surveillance. Lancet. 2009 Jun 5;373(9678):1861–1873.
  • Al-Akhali A, Ohkado A, Fujiki A. Nationwide survey on the prevalence of anti-tuberculosis drug resistance in the Republic of Yemen, 2004. Int J Tuberc Lung Dis. 2007 Dec;11(12):1328–1333.
  • Al-Hajoj S, Varghese B, Shoukri MM, et al. Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey. Antimicrob Agents Chemother. 2013 May;57(5):2161–2166. .
  • Cakir E, Erdem E, Ozlu N, et al. Demographic and microbial characteristics and drug resistance of childhood tuberculosis in Istanbul: analysis of 1,541 cases. J Infect Dev Ctries. 2014 March;8(3):304–309.
  • Pourakbari B, Mamishi S, Mohammadzadeh M, et al. First-line anti-tubercular drug resistance of mycobacterium tuberculosis in IRAN: a systematic review. Front Microbiol. 2016;7:1139.
  • Gupta A, Kulkarni S, Rastogi N, et al. A study of mycobacterium tuberculosis genotypic diversity & drug resistance mutations in Varanasi, north India. Indian J Med Res. 2014 Jun;139(6):892–902.
  • Subhash HS, Ashwin I, Jesudason MV, et al. Clinical characteristics and treatment response among patients with multidrug-resistant tuberculosis: a retrospective study. Indian J Chest Dis Allied Sci. 2003 Jun;45(2):97–103.
  • Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax. 2006 Feb;61(2):158–163.
  • Zhang C, Wang Y, Shi G, et al. Determinants of multidrug-resistant tuberculosis in Henan province in China: a case control study. BMC Public Health [Internet]. 2015 Dec [cited 2016 Nov 26];16(1). Available from: http://www.biomedcentral.com/1471-2458/16/42
  • World Health Organization. Global tuberculosis report 2016 [Internet]. 2016 [cited 2016 Dec 14]. Available from: http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf
  • Mor Z, Goldblatt D, Kaidar-Shwartz H, et al. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes. Int J Tuberc Lung Dis. 2014 Oct 1;18(10):1195–1201.
  • Robert J, Trystram D, Truffot-Pernot C, et al. Surveillance of mycobacterium tuberculosis drug resistance in France, 1995–1997. AZAY mycobacteria study group. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2000 Jul;4(7):665–672.
  • Sculier D, Gétāhun H, World Health Organization. WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders [Internet]. 2012 [cited 2016 Dec 14]. Available from: http://whqlibdoc.who.int/publications/2012/9789241503006_eng_Annexes.pdf